Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
filingDate |
1995-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fbaf036af84d5dfb5207b1345b38a49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51b918336422bef40aa4c4548674c0b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a1e6b73485c26d1072e841a5c52c3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02ed1a1fbb5ad23b2a2727a04d18416e |
publicationDate |
2000-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
SK-281098-B6 |
titleOfInvention |
PHARMACEUTICAL FORM AND / OR PREVENTION OF BONE DISEASE WITH FARMECEUTICALLY EFFECTIVE AMOUNT OF ALENDRONATE |
abstract |
Disclosed is a pharmaceutical composition comprising a pharmaceutically effective amount of alendronate in a pharmaceutically acceptable carrier, further comprising a buffer to maintain the pH of the composition in the range of 2 to 8 and a complexing agent to prevent the precipitation of alendronate in aqueous solution in an amount of 0.005 to 0.1 wt. relative to the device as a whole. It is used in the form of a syrup, an aqueous solution and a solution formed from a powder to reconstitute the original composition. It is intended for the treatment and / or prevention of bone loss for patients with swallowing difficulties |
priorityDate |
1994-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |